Firefly Luciferase - RPMI 8226 Recombinant Cell Line

Firefly Luciferase - RPMI 8226 Recombinant Cell Line
Artikelnummer
BPS79834
Verpackungseinheit
2 vials
Hersteller
BPS Bioscience

Verfügbarkeit: wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€

Applications: Use as a control for co-culture killing assays.

Background: RPMI 8226 cells are human B cells isolated from a plasmacytoma/myeloma patient. RPMI 8226 cells constitutively express B-Cell Maturation Antigen (BCMA), and offer a physiologically relevant platform to evaluate cancer-directed immunotherapies, such as Chimeric Antigen Receptor (CAR) T cells. The Firefly Luciferase - RPMI 8226 Recombinant Cell Line makes an excellent target to measure specific killing of CAR-T or NK cells targeting BCMA.

Description: Recombinant RPMI 8226 cells constitutively expressing firefly (Photinus pyralis) luciferase.

Genbank: BAA93575.1

Host Cell Line: RPMI 8226

Mycoplasma Testing: This cell line has been screened using the Venor™ GeM Mycoplasma Detection Kit, PCR Based (Sigma, #MP0025) to confirm the absence of Mycoplasma contamination.

Storage Stability: Store in liquid nitrogen immediately upon receipt.

Supplied As: Each vial contains 2 x 10^6 cells in 1 ml of FBS with 10% DMSO.

Warnings: Avoid multiple freeze/thaw cycles.

Biosafety Level: BSL-1
Mehr Informationen
Artikelnummer BPS79834
Hersteller BPS Bioscience
Hersteller Artikelnummer 79834
Verpackungseinheit 2 vials
Mengeneinheit PAK
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF)
×